Psychopathy facets and suicide risk among violently injured adults

• by Nicholas D. Thomson, Brooklyn A. Worthen, Jessica J. James

• June 22, 2026

Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam

• by Caitlyn Norman, Dean Acreman, Meera Bissram, Blake Curtis, Sebastian Hamer, Folker Westphal, Michael Putz, Cristiana Stefan, Sarah R. Delaney, Rick Lines, Malcolm D. McLeod, Karen McDonald, Henrik Green

• May 20, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Test-Retest Reliability of Standardized Diagnostic Interviews for Common Adult Psychiatric Disorders: A

• by Weiyi Xie, Julie Nordgaard, R. Christopher Sheldrick, Juwairiya F. Ahmad, Fabiano A. Gomes, Benicio N. Frey, Laura Duncan

• May 28, 2026